| | |

Tag search: "Hepatitis C"

WHO elections

WHO wants to tap Malaysia’s medical expertise, says Health D-G

The Malaysian health director Dr Abdullah said on his Facebook page that newly elected WHO director general Tedros Adhanom was particularly fascinated with the progress of Malaysia’s work on Hepatitis C curative treatment in collaboration with Drug for Neglected Diseases initiatives. He said WHO is looking into harnessing out expertise on this unique model of the research ecosystem in Malaysia to bring down the cost of medicine

May 27, 2017
Star Malaysia

Non communicable diseases

Hepatitis Infection May Raise Risk for Parkinson's Disease

People with the liver infection hepatitis may be at heightened risk of developing Parkinson’s disease, a large new study suggests. The study is the second in the past year to link Parkinson’s and hepatitis

March 30, 2017
Drugs.com

1 in 5 Indians suffers from liver disease: Doctors

One in every five Indians suffers from liver disease for which alcohol consumption and Hepatitis C are found to be the top causes. As many as 30% of Indians suffer from fatty liver and a quarter of this number develop liver cirrhosis and liver failure

March 25, 2017
Deccan Chronicle

Health systems

We can cure hepatitis C. But we’re now making the same mistake we did with AIDS

The World Health Organization now reports that 4 out of 5 people infected with hepatitis C aren’t even aware of it. Of those who do know, fewer than 1 in 50 have received treatment. These numbers are far worse in parts of South Asia and sub-Saharan Africa, where the majority of the global extreme poor live. In many places, such as Rwanda, infected patients remain on waiting lists for treatment, without which many succumb early to liver failure, cancer and other related complications. This is a failure not of science but of delivery

July 29, 2017
Washington Post

Hepatitis drugs more affordable but disease still deadly: WHO

Prices of drugs to cure hepatitis C and to treat hepatitis B are dropping dramatically, offering affordability and hope to 325 million people living with the viral liver disease that can be fatal, the World Health Organisation said. A generic antiviral drug for hepatitis C, which can be cured in three months, was placed this week on WHO`s list of pre-qualified medicines. That means it can be used safely by aid agencies and countries for bulk purchasing

July 27, 2017
Reuters

Britain to hold inquiry into contaminated blood scandal which killed 2,400

Britain will hold a public inquiry into contaminated blood supplied to patients in the National Health Service which killed at least 2,400 people. During the 1970s and 1980s, blood products supplied to the NHS were contaminated with viruses such as HIV or hepatitis C and infected thousands of people with haemophilia or other disorders. A report by lawmakers in 2015 said the Department of Health estimated that more than 30,000 people might have been infected with hepatitis C between 1970 and 1991 when Britain imported some blood products from the United States but just 6,000 had been identified. A further 1,500 were infected with HIV between 1978 and 1985

July 11, 2017
Reuters, Bloomberg
July 14, 2017
BBC
July 11, 2017
CNN

Transfusions happening in Nepal without testing blood for deadly diseases

No hospital in Nepal has the necessary kit to test blood for HIV during the crucial ‘window period.’ According to NCASC, since July 2016, 116 people have contracted HIV due to transfusion of blood and blood. This figure is 0.4 per cent of the total 28,865 HIV cases in Nepal. “The collected blood should be tested for Hepatitis B, Hepatitis C, HIV and Syphilis,” NPHL Director Dr Raj Kumar Mahato said

June 14, 2017
Himalayan Times

Cómo no discriminar en estrategia de hepatitis C

El Economista Mexico praises the IMSS plans to offer a coordinated innovative therapy to combat hepatitis C virus. However, it points out that only patients fortunate enough to enter the IMSS will benefit and this highlights the postcode lottery impact of the healthcare system which means you get better treatment depending on which part of the health system you connect with. Other experts are wondering why only the IMSS and not other institutions, resulting in expensive therapies for the few, not for all. NGOs are asking the government for clarity on who can access this treatment and on what conditions. Finally, what about people with co-infections such as HIV and their progression to advanced hepatitis stages – how is the new treatment going to relate to this group?

May 9, 2017
El Economista

Communicable diseases

Expecting mothers with hepatitis C have 90% chance of infecting their babies

Worryingly, there has been an eight per cent rise in the number of HCV cases among pregnant women in the last decade. Experts say that babies born with HCV often have a mild liver disease and around 80 per cent have very low to no liver scarring in the first 18 years. However, the actual nature of the disease becomes apparent once the child reaches adulthood as HCV usually takes more than a decade to cause liver problems — but whenever it happens, it is disastrous

July 28, 2017
India.com, The Health Site

500,000 Malaysians likely have hepatitis C

About half a million Malaysians are believed to have hepatitis C, said Health Minister S. Subramaniam, adding that many were unaware they had been infected with the virus because of a lack of awareness about the disease. If left untreated, hepatitis C could be fatal, or lead to liver cancer or cirrhosis

July 22, 2017
Straits Times

New Hepatitis C Infections Reach 15-Year High

Preliminary surveillance data released by the CDC shows that the number of reported hepatitis C virus cases has almost tripled in number from 2011-15 reaching a 15 year high. The CDC attributes the rising numbers among younger individuals primarily to injection drug use related to the ongoing opioid epidemic in the USA. However, younger individuals are not the most affected by HCV, Baby Boomers are

May 12, 2017
Contagion Live
May 13, 2017
Debate
May 12, 2017
Last Minute
May 11, 2017
Bloomberg

WHO Report Slashes Number of Worldwide Hepatitis C Cases

The estimated number of individuals living with hepatitis C virus worldwide has been slashed in half by a new WHO report. Surprisingly the drop has little to do with the release of lifesaving HCV drugs. The dramatic decrease is largely due to tests that measure patients’ RNA, rather than seroprevalence, which are less precise. The meta-analysis of studies conducted in sub-Saharan Africa showed that only 51% of patients diagnosed as positive from antibody tests had evidence of viral RNA. The inaccuracy is because patients can spontaneously clear the virus, while the antibodies will hang around – so the issue is more due to diagnostic tests rather than treatment

May 2, 2017
Specialty Pharmacy Times

Candidato a director de la OMS: "Los laboratorios deben bajar los precios a los paises pobres"

On a visit to Guatemala to learn more about the health challenges the country is facing, David Nabarro, candidate to be the next Director General of WHO, said ‘pharmaceutical companies should seek to find a way in which to reduce prices for medicines in poorer countries’

March 29, 2017
America Economica
March 28, 2017
Noticias Terra, La Conexion USA, Emisoras Unidas 89.7